Subscribe To
KHRNF / Khiron Life Sciences Corp. (KHRNF) Q2 2022 Earnings Call Transcript
KHRNF News
By Seeking Alpha
November 30, 2022
Khiron Life Sciences Corp. (KHRNF) Q3 2022 Earnings Call Transcript
Khiron Life Sciences Corp. (OTCQX:KHRNF) Q3 2022 Earnings Conference Call November 30, 2022 11:00 AM ET Company Participants Alvaro Torres - CEO and C more_horizontal
By PRNewsWire
November 18, 2022
Khiron to Host Third Quarter 2022 Conference Call on November 30, 2022
TORONTO , Nov. 18, 2022 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMXC), the glo more_horizontal
By Seeking Alpha
August 29, 2022
Khiron Life Sciences Corp. (KHRNF) Q2 2022 Earnings Call Transcript
Khiron Life Sciences Corp. (OTCQX:KHRNF) Q2 2022 Earnings Conference Call August 29, 2022 10:00 AM ET Company Participants Paola Ricardo - Investor Re more_horizontal
By Benzinga
June 2, 2022
Khiron Life Sciences Raises C$4M Via Equity Offering
Khiron Life Sciences Corp. (TSXV: KHRN) (OTC: KHRNF) has priced and sized its overnight marketed public offering. The company intends to issue 26.70 more_horizontal
By Seeking Alpha
May 2, 2022
Khiron Life Sciences' (KHRNF) CEO Alvaro Torres on Q4 2021 Results - Earnings Call Transcript
Khiron Life Sciences Corp. (OTCQX:KHRNF) Q4 2021 Earnings Conference Call May 2, 2022 10:00 AM ET Company Participants Alvaro Torres – Chief Executi more_horizontal
By PRNewsWire
March 7, 2022
Khiron Life Sciences to Present at Upcoming March Investor Conferences
TORONTO , March 7, 2022 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN)(OTCQX: KHRNF)(Frankfurt: A2JMZC), a medical more_horizontal
By PRNewsWire
March 7, 2022
Khiron Life Sciences to Present at Upcoming March Investor Conferences
TORONTO , March 7, 2022 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN)(OTCQX: KHRNF)(Frankfurt: A2JMZC), a medical more_horizontal
By PRNewsWire
March 7, 2022
Khiron Life Sciences to Present at Upcoming March Investor Conferences
TORONTO , March 7, 2022 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN)(OTCQX: KHRNF)(Frankfurt: A2JMZC), a medical more_horizontal